New U.S. guidance on pharmacologic management of rheumatoid arthritisRecommendations for use of various types of disease-modifying antirheumatic drugs and glucocorticoids, including use in certain high-risk populations. Aspirin and other common anti-inflammatory drugs could help prevent COVID-19 deaths, says pharmacy researcherDrugs could offer safer treatment than current options to help stop worst outcomes due to hyperinflammation. Guidance on myocarditis/pericarditis now included in COVID-19 vaccine guidelines NACI advises deferral of second dose in patients who develop myocarditis or pericarditis following the first dose of an mRNA COVID-19 vaccine. Model links contaminants from drug-making process to potential DNA damage A model by UBC researchers using yeast suggests that contaminants created during the drug manufacturing process may damage DNA. Transplant recipients may benefit from three doses of COVID-19 vaccine French study shows significant boost in antibodies after a third dose of Pfizer–BioNTech COVID-19 vaccine in more than 100 transplant recipients. Case report: The blues Dr. Robert Dickson has another unusual case: A 65-year-old fair skinned female with a rash of irregular, superficial blue lines just under the skin on her shoulder. B.C. woman files lawsuit against Northern Health citing medical negligence in son's death Montreal hospital experiments with using remote supervisors during surgery Reports of myocarditis/pericarditis after COVID-19 vaccination No clear association to date, but authorities are closely following emerging evidence. Gout medication shows potential for secondary prevention of cardiovascular events “Inflammation has emerged as an important therapeutic target in patients with atherosclerosis." First Previous 109 110 111 112 113 Next Last
